SELECT FROM MENU

Therapy Area
Drug Classes

       Disease Area

All Sessions

All Sessions

All Sessions

Resectable NSCLC

All Sessions

Metastatic NSCLC

All Sessions

SCLC

All Sessions

Biomarkers

       Drug Class

Targeted Therapies

Targeted Therapies

Immuno-therapies

Immuno-therapies

Antibody-Drug Conjugates

Antibody-Drug Conjugates

Stephen Finn

Stephen Finn

Trinity College Dublin and St James's Hospital, Dublin

Prof. Stephen Finn is an Associate Professor of Histopathology and Consultant Pathologist at Trinity College Dublin and St James’s Hospital in Dublin, Ireland. He leads the institution’s Thoracic Oncology Research Group, with translational research spanning lung cancer biomarker discovery, targeted therapies, and liquid biopsy using circulating tumour DNA and cells. He is Clinical Lead for Solid Tumour Molecular Diagnostics, co-director of the Cancer Molecular Diagnostic Laboratory, a member of the European Thoracic Oncology Platform, and associate editor of Lung Cancer. He previously worked at the Dana-Farber Cancer Institute in Boston. He is a frequent speaker at major international thoracic oncology congresses.

Connect

Stephen Finn

Featured in

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Indication Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immunotherapies

Antibody Drug Conjugates

Antibody-Drug Conjugates